Joint Transnational Call 2014 – Funded Projects

Joint Transnational Call (JTC2014)

These projects were funded under E-Rare.

General information
Topic: Development of Innovative Therapeutic Approaches for Rare Diseases
Budget: 10,8 Million €
Funded projects: 14
The following parties have decided to open the sixth E-Rare joint transnational call (JTC 2014) for funding multilateral research projects for promoting the development of innovative therapeutic approaches on rare diseases:

  • The Austrian Science Fund (FWF), Austria
  • The Research Foundation – Flanders (FWO), Belgium, Flanders
  • The Canadian Institutes of Health Research – Institute of Genetics (CIHR-IG), Canada
  • Le Fonds de recherche du Québec-Santé (FRQS), Québec (Canada)
  • The French National research Agency (ANR), France
  • The Federal Ministry of Education and Research (BMBF), Germany
  • The Hungarian Scientific Research Fund (OTKA), Hungary
  • The Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel
  • The Italian Ministry of Health (MoH), Italy
  • The Latvian Academy of Sciences (LAS), Latvia
  • The National Centre for Research and Development (NCBiR), Poland
  • The Foundation for Science and Technology (FCT), Portugal
  • The Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI), Romania
  • The National Institute of Health Carlos III (ISCIII), Spain
  • The Swiss National Science Foundation (SNSF), Switzerland
  • The Netherlands Organization for Health Research and Development (ZonMw), The Netherlands
  • The Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey
  • Treat-AID: New treatments for auto-inflammatory diseases
  • Drug_FXSPreMut: Preclinical approaches towards therapeutic intervention for fragile X premutation carriers
  • EBThera: Repurposing biomolecules for the treatment of epidermolysis bullosa
  • RescueCFTRpreclinic: Cysteamine for the treatment of cystic fibrosis: a translational research project
  • CHAPRION: Pharmacological chaperones for genetic prion diseases
  • EURO-CMC: Novel treatment strategies for autosomal dominant chronic mucocutaneous candidiasis
  • TREAT-NEMMYOP: Fast Skeletal Troponin Activation for Restoring Muscle Strength in Mouse Models of Nemaline Myopathy: a Molecular, Cellular, Metabolic and Functional Assessment
  • ARTEMIS: Targeting Alpha-Synuclein for Treating Multiple System Atrophy
  • NTC study: Novel Therapies for Cystinosis
  • CantuTreat: Sulfonylurea drugs to treat Cantú syndrome
  • PrionImmunity: Immunotherapy of familial prion diseases
  • CCMCURE: Cerebral Cavernous Malformations Pharmacological Supression Screen
  • FaSMALS: Common Pathogenic Pathways and Therapeutics for SMA and ALS motoneuron diseases
  • TheraLymp: Therapeutic approaches for treatment of hereditary lymphedema